Blood 100:765a, 2002
Methods : Animals : Studies were performed in male mice of varying ages
Customized packaging: If you have any idea of the packaging, please feel free to share with us, we will try our best to meet your need
4032-A COMPARISON OF PROGNOSTIC IMPACT OF ATEZOLIZUMAB PLUS BEVACIZUMAB VERSUS LENVATINIB AS FIRST-LINE SYSTEMIC THERAPY IN PATIENTS WITH INTERMEDIATE-STAGE HCC Toshifumi Tada 1 , Takashi Kumada 2 , Atsushi Hiraoka 3 , Masashi Hirooka 2 , Kazuya Kariyama 4 , Ei Itobayashi 2 , Tsuji Kunihiko 2 , Toru Ishikawa 2 , Hidenori Toyoda 2 , Takeshi Hatanaka 2 , Satoru Kakizaki 5 , Fujimasa Tada 3 , Hideko Ohama 6 , Kazuhiro Nouso 7 , Tomomitsu Matono 8 , Yutaka Yata 9 , Yoichi Hiasa 10 and Masatoshi Kudo 11 , (1)Japanese Red Cross Society Himeji Hospital, (2)Relpec Study Group and HCC 48 Group, (3)Ehime Prefectural Central Hospital, (4)Okayama City Hospital, (5)National Hospital Organization Takasaki General Medical Center, Takasaki, Gunma, Japan, (6)Takarazuka City Hospital, (7)Okayama City Hosipital, (8)St
Bodycare (March 2024 to February 2026) Theres an increasing focus on functional, treatment-led bodycare products that deliver targeted results